vs
Side-by-side financial comparison of Datadog (DDOG) and Dexcom (DXCM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $953.2M, roughly 1.3× Datadog). Dexcom runs the higher net margin — 21.2% vs 4.9%, a 16.3% gap on every dollar of revenue. On growth, Datadog posted the faster year-over-year revenue change (29.2% vs 21.6%). Over the past eight quarters, Datadog's revenue compounded faster (24.9% CAGR vs 12.0%).
Datadog, Inc. is an American company that provides an observability service for cloud-scale applications, providing monitoring of servers, databases, tools, and services, through a SaaS-based data analytics platform. Founded and headquartered in New York City, the company is a publicly traded entity on the Nasdaq stock exchange.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
DDOG vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $953.2M | $1.3B |
| Net Profit | $46.6M | $267.3M |
| Gross Margin | 80.4% | 62.9% |
| Operating Margin | 1.0% | 25.6% |
| Net Margin | 4.9% | 21.2% |
| Revenue YoY | 29.2% | 21.6% |
| Net Profit YoY | 2.1% | 153.6% |
| EPS (diluted) | $0.13 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $953.2M | $1.3B | ||
| Q3 25 | $885.7M | $1.2B | ||
| Q2 25 | $826.8M | $1.2B | ||
| Q1 25 | $761.6M | $1.0B | ||
| Q4 24 | $737.7M | $1.1B | ||
| Q3 24 | $690.0M | $994.2M | ||
| Q2 24 | $645.3M | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $46.6M | $267.3M | ||
| Q3 25 | $33.9M | $283.8M | ||
| Q2 25 | $2.6M | $179.8M | ||
| Q1 25 | $24.6M | $105.4M | ||
| Q4 24 | $45.6M | $151.7M | ||
| Q3 24 | $51.7M | $134.6M | ||
| Q2 24 | $43.8M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | 80.4% | 62.9% | ||
| Q3 25 | 80.1% | 60.5% | ||
| Q2 25 | 79.9% | 59.5% | ||
| Q1 25 | 79.3% | 56.9% | ||
| Q4 24 | 80.5% | 58.9% | ||
| Q3 24 | 80.0% | 59.7% | ||
| Q2 24 | 80.9% | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 1.0% | 25.6% | ||
| Q3 25 | -0.7% | 20.1% | ||
| Q2 25 | -4.3% | 18.4% | ||
| Q1 25 | -1.6% | 12.9% | ||
| Q4 24 | 1.3% | 17.0% | ||
| Q3 24 | 2.9% | 15.3% | ||
| Q2 24 | 2.0% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | 4.9% | 21.2% | ||
| Q3 25 | 3.8% | 23.5% | ||
| Q2 25 | 0.3% | 15.5% | ||
| Q1 25 | 3.2% | 10.2% | ||
| Q4 24 | 6.2% | 13.6% | ||
| Q3 24 | 7.5% | 13.5% | ||
| Q2 24 | 6.8% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.13 | $0.67 | ||
| Q3 25 | $0.10 | $0.70 | ||
| Q2 25 | $0.01 | $0.45 | ||
| Q1 25 | $0.07 | $0.27 | ||
| Q4 24 | $0.14 | $0.37 | ||
| Q3 24 | $0.14 | $0.34 | ||
| Q2 24 | $0.12 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $401.3M | $917.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.7B | $2.7B |
| Total Assets | $6.6B | $6.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $401.3M | $917.7M | ||
| Q3 25 | $540.6M | $1.8B | ||
| Q2 25 | $489.0M | $1.2B | ||
| Q1 25 | $1.1B | $904.9M | ||
| Q4 24 | $1.2B | $606.1M | ||
| Q3 24 | $337.4M | $621.2M | ||
| Q2 24 | $411.0M | $939.2M |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $3.7B | $2.7B | ||
| Q3 25 | $3.4B | $2.7B | ||
| Q2 25 | $3.2B | $2.6B | ||
| Q1 25 | $2.9B | $2.3B | ||
| Q4 24 | $2.7B | $2.1B | ||
| Q3 24 | $2.6B | $2.0B | ||
| Q2 24 | $2.4B | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $6.6B | $6.3B | ||
| Q3 25 | $6.1B | $7.5B | ||
| Q2 25 | $5.8B | $7.3B | ||
| Q1 25 | $6.0B | $6.8B | ||
| Q4 24 | $5.8B | $6.5B | ||
| Q3 24 | $4.6B | $6.4B | ||
| Q2 24 | $4.4B | $6.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $327.1M | — |
| Free Cash FlowOCF − Capex | $318.2M | — |
| FCF MarginFCF / Revenue | 33.4% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 7.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $327.1M | $294.0M | ||
| Q3 25 | $251.5M | $659.9M | ||
| Q2 25 | $200.1M | $303.0M | ||
| Q1 25 | $271.5M | $183.8M | ||
| Q4 24 | $265.2M | $301.4M | ||
| Q3 24 | $228.7M | $199.5M | ||
| Q2 24 | $164.4M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | $318.2M | $192.1M | ||
| Q3 25 | $234.7M | $579.4M | ||
| Q2 25 | $184.9M | $208.9M | ||
| Q1 25 | $262.8M | $96.8M | ||
| Q4 24 | $257.5M | $176.8M | ||
| Q3 24 | $220.3M | $88.3M | ||
| Q2 24 | $160.0M | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | 33.4% | 15.3% | ||
| Q3 25 | 26.5% | 47.9% | ||
| Q2 25 | 22.4% | 18.1% | ||
| Q1 25 | 34.5% | 9.3% | ||
| Q4 24 | 34.9% | 15.9% | ||
| Q3 24 | 31.9% | 8.9% | ||
| Q2 24 | 24.8% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 8.1% | ||
| Q3 25 | 1.9% | 6.7% | ||
| Q2 25 | 1.8% | 8.1% | ||
| Q1 25 | 1.1% | 8.4% | ||
| Q4 24 | 1.1% | 11.2% | ||
| Q3 24 | 1.2% | 11.2% | ||
| Q2 24 | 0.7% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 7.02× | 1.10× | ||
| Q3 25 | 7.42× | 2.33× | ||
| Q2 25 | 75.58× | 1.69× | ||
| Q1 25 | 11.02× | 1.74× | ||
| Q4 24 | 5.82× | 1.99× | ||
| Q3 24 | 4.42× | 1.48× | ||
| Q2 24 | 3.75× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DDOG
| North America | $678.7M | 71% |
| International | $274.5M | 29% |
DXCM
Segment breakdown not available.
